Sunshine Biopharma, Inc - SBFM

Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer. It engages in the development of Adva-27a, which is a GEM-difluorinated C-glycoside derivative of podophyllotoxin for the treatment of leukemia, lymphoma, testicular cancer, lung cancer, brain cancer, prostate cancer, bladder cancer, colon cancer, ovarian cancer, liver cancer, and other forms of cancer. It also provides generic prescription drugs for the treatment breast and prostate cancer, benign prostatic hyperplasia, and other acute and chronic indications; and chemical analysis of pharmaceutical and other industrial samples. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.